Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Rotschafer

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Diagnostic Microbiology and Infectious Disease|March 26, 1999
Gram-positive infections: pharmacy issues and strategy for quinupristin/dalfopristinJ C Rotschafer, D H Wright, G H Brown
DICP : the Annals of Pharmacotherapy|March 1, 1990
Aminoglycosides: another perspectiveM W Garrison, D E Zaske, J C Rotschafer
The Journal of Antimicrobial Chemotherapy|August 15, 2003
Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilisM L Peterson, J C Rotschafer, L J V Piddock
The Journal of Antimicrobial Chemotherapy|April 1, 1996
A pharmacodynamic evaluation of ciprofloxacin and ofloxacin against two strains of Pseudomonas aeruginosaK J Madaras-Kelly, A J Larsson, J C Rotschafer
Therapeutic Drug Monitoring|January 1, 1989
Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian modelsR D Pryka, K A Rodvold, M Garrison, et al.
Pharmacotherapy|January 5, 2002
In vitro pharmacodynamic analysis of single daily dosing versus conventional dosing of gentamicin administered with penicillin against Enterococcus faecalisG H Ross, L B Hovde, Y H Ibrahim, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic modelK J Walker, A J Larsson, R A Zabinski, et al.
Journal of Clinical Microbiology|October 1, 1983
Comparison of radioimmunoassay and fluorescent polarization immunoassay for quantitative determination of vancomycin concentrations in serumB H Ackerman, H G Berg, R G Strate, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1984
Effect of decreased renal function on the pharmacokinetics of ceftazidimeB H Ackerman, J Ross, R W Tofte, et al.
Therapeutic Drug Monitoring|January 1, 1989
Evaluation of a two-compartment Bayesian forecasting program for predicting vancomycin concentrationsK A Rodvold, R D Pryka, M Garrison, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Diagnostic Microbiology and Infectious Disease|March 26, 1999
Gram-positive infections: pharmacy issues and strategy for quinupristin/dalfopristinJ C Rotschafer, D H Wright, G H Brown
DICP : the Annals of Pharmacotherapy|March 1, 1990
Aminoglycosides: another perspectiveM W Garrison, D E Zaske, J C Rotschafer
The Journal of Antimicrobial Chemotherapy|August 15, 2003
Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilisM L Peterson, J C Rotschafer, L J V Piddock
The Journal of Antimicrobial Chemotherapy|April 1, 1996
A pharmacodynamic evaluation of ciprofloxacin and ofloxacin against two strains of Pseudomonas aeruginosaK J Madaras-Kelly, A J Larsson, J C Rotschafer
Therapeutic Drug Monitoring|January 1, 1989
Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian modelsR D Pryka, K A Rodvold, M Garrison, et al.
Pharmacotherapy|January 5, 2002
In vitro pharmacodynamic analysis of single daily dosing versus conventional dosing of gentamicin administered with penicillin against Enterococcus faecalisG H Ross, L B Hovde, Y H Ibrahim, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic modelK J Walker, A J Larsson, R A Zabinski, et al.
Journal of Clinical Microbiology|October 1, 1983
Comparison of radioimmunoassay and fluorescent polarization immunoassay for quantitative determination of vancomycin concentrations in serumB H Ackerman, H G Berg, R G Strate, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1984
Effect of decreased renal function on the pharmacokinetics of ceftazidimeB H Ackerman, J Ross, R W Tofte, et al.
Therapeutic Drug Monitoring|January 1, 1989
Evaluation of a two-compartment Bayesian forecasting program for predicting vancomycin concentrationsK A Rodvold, R D Pryka, M Garrison, et al.
Pageof 9